drugset / Trial / NCT07100964
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood
NaSequentialOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of carbamazepine on pharmacokinetics of nerandomilast.
Timeline
- Start
- 2025-08-11
- Primary completion
- 2025-09-20
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | — | — |
| Subject | Nerandomilast | Small molecule | — | — |
Indications
No indication recorded.